GlassScriptPhysician profile
Marijan Gospodnetic
NPI 1619957818
$368.33
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $283 · 2020: $85.70.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $57.97 | 2019 | |
| Abbvie INC. | $43.83 | 2019 | |
| Astellas Pharma US INC | $34.51 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $32.17 | 2019 | |
| Merck Sharp & Dohme LLC | $29.57 | 2019-2020 | |
| Amgen INC. | $27.10 | 2019 | |
| Duchesnay USA Incorporated | $24.10 | 2019 | |
| Daiichi Sankyo INC. | $22.14 | 2020 | |
| Coopersurgical, INC. | $16.51 | 2020 | |
| Therapeuticsmd, INC. | $15.96 | 2019 | |
| Hologic Sales and Service, LLC | $15.62 | 2019 | |
| Smith+Nephew, INC. | $14.03 | 2019 | |
| Avion Pharmaceuticals | $12.56 | 2020 | |
| Lupin INC. | $11.43 | 2019 | |
| Vertical Pharmaceuticals, LLC | $10.83 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marijan Gospodnetic listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.